Liraglutide vs Semaglutide
Overview
Liraglutide and Semaglutide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Liraglutide and Semaglutide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Liraglutide | Semaglutide | |
|---|---|---|
| Category | Weight Management & Metabolic | Weight Management & Metabolic |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 0.6-3.0 mg | 0.25-2.4 mg |
| Frequency | daily | weekly |
| Reported benefits | Weight loss, blood sugar control, cardiovascular protection | Significant weight loss, improved blood sugar control, reduced cardiovascular risk, appetite suppression |
| Reported side effects | Nausea, GI disturbances, potential pancreatitis | Nausea, vomiting, diarrhea, constipation, potential pancreatitis risk |
Key differences
Primary use. Liraglutide is categorised under Weight Management & Metabolic, while Semaglutide falls under Weight Management & Metabolic. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Liraglutide: FDA-approved. Semaglutide: FDA-approved.
Dosing. Liraglutide is typically dosed at 0.6-3.0 mg (daily). Semaglutide is typically dosed at 0.25-2.4 mg (weekly).
Can you stack them?
Some protocols combine peptides, but stacking Liraglutide and Semaglutide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Liraglutide and Semaglutide?
- Liraglutide and Semaglutide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status. Liraglutide is FDA-approved for one or more indications, whereas Semaglutide is FDA-approved for one or more indications.
- What is Liraglutide used for?
- FDA-approved GLP-1 for weight loss.
- What is Semaglutide used for?
- Weight loss, blood sugar control.
- Can you take Liraglutide and Semaglutide together?
- Some users combine peptides within a single protocol, but stacking Liraglutide and Semaglutide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Liraglutide or Semaglutide FDA-approved?
- Liraglutide is FDA-approved for one or more indications. Semaglutide is FDA-approved for one or more indications.
Read the full articles
- Liraglutide — full monograph: mechanism, research, dosing & references
- Semaglutide — full monograph: mechanism, research, dosing & references